Table 2.

Echocardiographic parameters of the patients before and after L-carnitine supplementation

	Baseline	After 3 months
Placebo
Ejection fraction	56.4 ± 15.0	56.9 ± 13.8
Tei index	0.65 ± 0.18	0.54 ± 0.21
E/A	0.69 ± 0.35	0.60 ± 0.25
e/e′	15.9 ± 9.17	16.1 ± 9.51
S/D	1.73 ± 0.57	1.70 ± 0.50
LV mass index	109.4 ± 45.1	102.1 ± 22.3
Body weight	52.4 ± 15.4	52.9 ± 15.4
Systolic blood pressure	130.9 ± 17.4	136 ± 25.7
Diastolic blood pressure	76.3 ± 5.3	78.3 ± 13.2
Carnitine treated
Ejection fraction	61.8 ± 16.0	64.4 ± 13.8*
Tei index	0.46 ± 0.1	0.44 ± 0.06
E/A	0.63 ± 0.12	0.66 ± 0.11
e/e′	13.3 ± 4.25	13.1 ± 4.71
S/D	1.63 ± 0.51	1.93 ± 1.09
LV mass index	98.9 ± 15.0	97.1 ± 30.2
Body weight	53.7 ± 12.2	53.7 ± 12.1
Systolic blood pressure	136 ± 22.4	132.9 ± 17.2
Diastolic blood pressure	75 ± 7.1	73.5 ± 9.3

p values were calculated by paired t test.

^*p < 0.05.